Clinical study to compare the effectiveness of Ashwagandhadi transdermal gel and estrogen gel on the perimenopausal symptoms

Comparative clinical study on the effectiveness of Ashwagandhadi transdermal gel and estrogen gel on the perimenopausal symptoms - nil

Status

Active, not recruiting

Phases

Phase 2Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2025/03/083413

Enrollment

Registered

2025-03-25

Start date

Unknown

Completion date

Unknown

Last updated

2025-04-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N959- Unspecified menopausal and perimenopausal disorder

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: Fulfilling diagnostic criteria Major criteria 1 Hot flashes or night sweats 2 Fatigue 3 headache 4 irritability Minor criteria With or without 1.depression 2.vertigo 3.nervousness 4.Paresthesia 5.sexual complaints 6. urinary tract infections 7.palpitations 8. formication 9.arthralgia 10 myalgia 11 insomnia

Exclusion criteria

Exclusion criteria: 1. Any pre existing psychological disorder 2. Known case of uncontrolled Diabetes mellitus hypertension thyroid dysfunction

Design outcomes

Primary

Measure	Time frame
Remission in perimenopausal symptomsTimepoint: Remission in perimenopausal symptoms and assessed once in15 days for 8 weeks	—

Secondary

Measure	Time frame
relief from perimenopausal symptomsTimepoint: relief from perimenopausal symptoms which is assessed after 8 weeks	—

Countries

India

Contacts

Public ContactDr Gayathri Bhat N V

Sri Dharmasthala Manjunatheshwara College of Ayurveda and Hospital, Hassan

gaya3hassan@gmail.com9844437917

Outcome results